Delivery Order SPE2DR25D6028-SPE2DR26FARBD
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,136.83 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 mg patches (8-count) with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.93 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG patches (8-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for COMBIPATCH 0.05-0.14 MG transdermal patches (8-count packaging) with a ceiling value of $1,679.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for July 14, 2025, and performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a $3,430.71 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count units). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. Performance is scheduled for completion by September 3,...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.76 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count unit). This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract has an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,284.92 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 mg transdermal patches (8-count package) on September 24, 2025, with completion targeted for September 25, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,298.88 firm fixed-price delivery order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S medical patches, with a period of performance through November 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.82 firm fixed-price delivery order is for the supply of "COMBIPATCH 0.05-0.14 MG PTCH 8S", a pharmaceutical product, with a period of performance through March 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- The Defense Logistics Agency awarded a $2,254.84 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of COMBIPATCH 0.05-0.14 MG transdermal patches (8-count packaging), with completion expected by September 18, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $1,734.60, is a firm fixed price delivery order for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product. The contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARBDDelivery Order
The Defense Logistics Agency awarded a $1,295.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMBIPATCH TDBW 8S on October 29, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside contract represents a pediatric or specialized pharmaceutical delivery under the company's existing relationship with DLA's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems, delivering an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medical commodities to support military healthcare programs worldwide. The company's competitive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, with delivery orders ranging substantially in value. AmerisourceBergen Drug Corp serves critical customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/29/25 |